• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NUVECTRA CORPORATION ALGOVITA SPINAL CORD STIMULATION STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTABLE (PAIN RELIEF)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NUVECTRA CORPORATION ALGOVITA SPINAL CORD STIMULATION STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTABLE (PAIN RELIEF) Back to Search Results
Model Number 2412
Device Problem High impedance (1291)
Patient Problems Therapeutic Effects, Unexpected (2099); Injury (2348)
Event Date 08/09/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4). Due to issues with the portal set up process, this mdr has not been submitted. Nuvectra is actively working with the esg helpdesk at the fda ((b)(4)).
 
Event Description
On (b)(6) 2016 it was reported that the patient's stimulation was off and she was unable to start the stimulation. The ipg would not connect to the cp. It was possible to charge with the ppc and the ipg showed 3 bars. After charging with the ppc the connection between the cp and ipg was possible. The program was started and the patient felt the stimulation in the right spot. After a short period of time, the stimulation stopped when the patient moved. The impedances on both leads changed from normal to high. When the patient was not moving, all impedances were green. The patient was ok but without stimulation. On (b)(6) 2016, ipg, serial number (b)(4) was explanted and a new ipg was implanted. The leads were found to be in tact and are connected to the newly implanted ipg. There were no complications and patient is receiving therapy with the new ipg.
 
Manufacturer Narrative
(b)(4). Note to file: due to issues with the portal setup process and access, the initial report could not be submitted within 30 day (see esg tickets (b)(4)). Investigation: the device was evaluated by electrical engineer subject matter expert (sb). The device was found to have multiple issues with output pulse performance during device level functional stimulation testing, such as erratic impedance measurements and excessive channel crosstalk. Further testing required access to the inner components of the stimulator. The device was disassembled; all inner components were removed from the case and visually inspected. Visual inspection did not identify any damages or abnormalities. The printed circuit assembly ((b)(4)) was subjected to board level electrical testing. During manual testing of the pcb, the same impedance and crosstalk issues were observed to occur as were observed on the sealed ipg. However, after running the pcb through an automated test process, which includes reloading the device firmware and constants, the pcb functioned normally and no longer exhibited the issues. The board was then reloaded with the patient program that was received with the complaint device the dut operated nominally, with expected levels of channel crosstalk, no detectable "stim startup transients" and impedance measurement performance that meets specification. Numerous follow up tests were conducted over a two-week period while the dut was in continuous operation outputting various therapy programs; no deviation from expected nominal performance has been noted in those observations. The contract manufacturer of the device was notified of the issue. A process review identified that all inspections and functional tests met specification and acceptance criteria. The dhr review did not identify any anomalies that would be associated with this issue. Review of the manufacturing process did not identify a root cause for the issue. Root cause: no root cause identified. Conclusions: as received, the returned ipg showed issues with output pulse performance and impedance measurements during bench testing. During further investigation the pca was destructively removed from the returned device, and was subjected to board level electrical testing to determine a root cause for these anomalies. The extracted pcb initially demonstrated the same issue as with the sealed ipg, however, these issues were no longer present after the pcb underwent automated board level testing. The root cause of the difficulties experienced could not be identified. The problem condition can no longer be detected in the test device electronics. It is suspected that the problem condition was affected by exposing the test device to the conditions of automated board-level electrical test, however this could not be confirmed. The leads used were not returned for analysis, therefore, it could not be determined if they were damaged or contributed to the difficulties experienced.
 
Event Description
On july 9, 2016, it was reported that the patient's stimulation was off and she was unable to start the stimulation. The ipg would not connect to the cp. It was possible to charge with the ppc and the ipg showed 3 bars. After charging with the ppc, the connection between the cp and ipg was possible. The program was started and the patient felt the stimulation in the right spot. After a short period of time, the stimulation stopped when the patient moved. The impedances on both leads changed from normal to high. When the patient was not moving, all impedances were green. The patient was ok but without stimulation. On (b)(6) 2016, ipg, serial number (b)(4) was explanted and a new ipg was implanted. The leads were found to be in tact and are connected to the newly implanted ipg. There were no complications and patient is receiving therapy with the new ipg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameALGOVITA SPINAL CORD STIMULATION
Type of DeviceSTIMULATOR, SPINAL-CORD, TOTALLY IMPLANTABLE (PAIN RELIEF)
Manufacturer (Section D)
NUVECTRA CORPORATION
10675 naples street ne
blaine MN 55499
Manufacturer (Section G)
NUVECTRA CORPORATION
10675 naples street ne
blaine MN 55449
Manufacturer Contact
amy parker
10675 naples stree ne
blaine, MN 55449
7634047531
MDR Report Key6139834
MDR Text Key61289137
Report Number3010309840-2016-00009
Device Sequence Number1
Product Code LGW
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P130028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign
Reporter Occupation
Type of Report Initial,Followup
Report Date 08/09/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Device Expiration Date12/30/2016
Device Model Number2412
Device Catalogue Number2412
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/24/2016
Is the Reporter a Health Professional? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received08/09/2016
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 12/01/2016 Patient Sequence Number: 1
-
-